TriSalus Life Sciences, Inc. (TLSI)

NASDAQ: TLSI · Real-Time Price · USD

6.14

+0.04 (0.66%)

At close: Jan 8, 2026, 4:00 PM EST

6.14

0.00 (0.00%)

After-hours: Jan 8, 2026, 5:06 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Innovative Drug Delivery Technology and Immune-oncology Therapeutics	18.51M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	18.51M